ES2787699T3 - Bebida que contiene CBD - Google Patents

Bebida que contiene CBD Download PDF

Info

Publication number
ES2787699T3
ES2787699T3 ES15825932T ES15825932T ES2787699T3 ES 2787699 T3 ES2787699 T3 ES 2787699T3 ES 15825932 T ES15825932 T ES 15825932T ES 15825932 T ES15825932 T ES 15825932T ES 2787699 T3 ES2787699 T3 ES 2787699T3
Authority
ES
Spain
Prior art keywords
drink
cannabidiol
cbd
liquid formulation
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES15825932T
Other languages
English (en)
Spanish (es)
Inventor
Christian Steup
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thc Pharm Health Concept GmbH
Original Assignee
Thc Pharm Health Concept GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thc Pharm Health Concept GmbH filed Critical Thc Pharm Health Concept GmbH
Application granted granted Critical
Publication of ES2787699T3 publication Critical patent/ES2787699T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L35/00—Food or foodstuffs not provided for in groups A23L5/00 – A23L33/00; Preparation or treatment thereof
    • A23L35/10—Emulsified foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
ES15825932T 2014-12-19 2015-12-21 Bebida que contiene CBD Active ES2787699T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14199135 2014-12-19
PCT/EP2015/080894 WO2016097425A1 (de) 2014-12-19 2015-12-21 Cbd-haltiges getränk

Publications (1)

Publication Number Publication Date
ES2787699T3 true ES2787699T3 (es) 2020-10-16

Family

ID=52344961

Family Applications (1)

Application Number Title Priority Date Filing Date
ES15825932T Active ES2787699T3 (es) 2014-12-19 2015-12-21 Bebida que contiene CBD

Country Status (5)

Country Link
US (2) US20180020699A1 (en22)
EP (1) EP3232808B1 (en22)
DK (1) DK3232808T3 (en22)
ES (1) ES2787699T3 (en22)
WO (1) WO2016097425A1 (en22)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10738268B2 (en) * 2016-08-21 2020-08-11 Insectergy, Llc Cannabis nanoemulsion methods
US11026929B2 (en) 2016-04-19 2021-06-08 Keto Patent Group, Inc. Administration of berberine metabolites
EP3251668A1 (en) 2016-06-02 2017-12-06 Pharmotech SA Cannabidiol compositions and uses thereof
AU2018221739A1 (en) * 2017-02-15 2019-08-29 Molecular Infusions, Llc Formulations
CA3067232C (en) 2017-06-16 2023-06-20 Sorse Technology Corporation Preparing stable liquid emulsion forms of plant extract
US11013715B2 (en) * 2018-07-19 2021-05-25 Vertosa, Inc. Nanoemulsion hydrophobic substances
WO2020081357A1 (en) * 2018-10-16 2020-04-23 Golden Spice Liquors LLC Beverage compositions and methods of making and using the same
CN110604195A (zh) * 2019-09-10 2019-12-24 普洱茶王茶业集团股份有限公司 一种普洱茶保健饮品及其制备方法
US11975098B2 (en) 2020-05-22 2024-05-07 Colorado School Of Mines Nanosuspensions of cannabidiol for developing water-dispersible formulations
CA3198840A1 (en) * 2020-10-21 2022-04-28 Sorse Technology Corporation Clear plant extract emulsion and method for preparation
CN113604304A (zh) * 2021-09-02 2021-11-05 吴达镕 麻宝愫啤酒及其酿造方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL136839A (en) 2000-06-16 2006-12-10 Yissum Res Dev Co Pharmaceutical compositions comprising cannabidiol derivatives, and processes for the preparation of same
DE10051427C1 (de) 2000-10-17 2002-06-13 Adam Mueller Verfahren zur Herstellung eines Tetrahydrocannabinol- und Cannabidiol-haltigen Extraktes aus Cannabis-Pflanzenmaterial sowie Cannabis-Extrakte
GB2377633A (en) * 2001-05-11 2003-01-22 Gw Pharmaceuticals Ltd Pharmaceutical compositions comprising the cannabinoids THC and CBD
IL148244A0 (en) * 2002-02-19 2002-09-12 Yissum Res Dev Co Anti-nausea and anti-vomiting activity of cannabidiol compounds
US8911751B2 (en) * 2005-10-11 2014-12-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions for nasal delivery
CN101516333A (zh) 2006-08-04 2009-08-26 英西斯治疗学股份有限公司 水性屈大麻酚制剂
WO2010127033A1 (en) * 2009-04-28 2010-11-04 Alltranz Inc. Formulations of cannabidiol and methods of using the same
DE102009019322A1 (de) 2009-04-30 2010-11-11 The Health Concept Gmbh Verfahren zur Herstellung von Synthetischen Cannabinoiden
HUE026929T2 (en) * 2010-10-19 2016-08-29 Parenteral A S Composition for treating inflammatory diseases comprising boswellic acids and cannabidol
US8895537B2 (en) * 2010-10-29 2014-11-25 Infirst Healthcare Ltd. Compositions and methods for treating cardiovascular diseases
WO2013009928A1 (en) * 2011-07-11 2013-01-17 Organic Medical Research Cannabinoid formulations
US20130184354A1 (en) * 2012-01-13 2013-07-18 Donna K. Jackson Silicone and Hylauronic Acid (HLA) Delivery Systems for Products by Sustainable Processes for Medical Uses Including Wound Management

Also Published As

Publication number Publication date
DK3232808T3 (da) 2020-06-02
US20180020699A1 (en) 2018-01-25
EP3232808A1 (de) 2017-10-25
WO2016097425A1 (de) 2016-06-23
EP3232808B1 (de) 2020-04-01
US20210204568A1 (en) 2021-07-08

Similar Documents

Publication Publication Date Title
ES2787699T3 (es) Bebida que contiene CBD
ES2901901T3 (es) Nuevas composiciones nutracéuticas que contienen esteviol y uso de las mismas
US20100317727A1 (en) Rosemary extracts, dietary and pharmaceutical compostions containing them and their uses
TW200812567A (en) Agent for improving nervous system cell functions
EP2289528A1 (en) Novel nutraceutical compositions containing black pepper or its constituents improving mental performance
WO2016175136A1 (ja) 筋脂肪化抑制用組成物
ES2549116T3 (es) Uso de composiciones que contienen carnosol y/o rosmanol
JP2007124917A (ja) オリザノールを豊富に含んだ米油の製造法及びその用途
US20120149766A1 (en) Dietary and pharmaceutical compositions comprising a sage extract containing a mixture of tricyclic diterpenes and their derivatives and their uses
WO2006042441A2 (en) Novel agents for preventing and treating disorders connected to impaired neurotransmission
US20090221693A1 (en) Novel use of organic compounds
CA2810793C (en) Sphaeranthus indicus derived ingredients and their compositions for enhancing physical performance and energy levels
ES2319049B1 (es) Composicion que comprende hidrolizado de colageno y acido hialuronico para la mejora de dificultades funcionales consecutivas a alteraciones de los cartilagos articulares.
FR3040628A1 (fr) Produit de combinaison pour aider a la relaxation et a l'endormissement
JP6916422B2 (ja) 骨吸収抑制用組成物及び骨吸収抑制用食品組成物
WO2020072997A1 (en) Method and composition for relieving fatigue and restoring energy
CA3005047C (en) Composition of olivetol and method of use reduce or inhibit the effects of tetrahydrocannabinol in the human body
JP2006213628A (ja) 抗ストレス剤
WO2021193703A1 (ja) 中枢神経賦活組成物
JP2014152118A (ja) 老化抑制剤
JP7371851B2 (ja) 肉体的疲労及び疲労感を予防又は改善するオレアナン型トリテルペンを含有する組成物
KR101409111B1 (ko) 카페산 또는 이의 염을 포함하는 여드름 치료 또는 예방용 조성물
US10265277B2 (en) Composition of Olivetol and method of use to reduce or inhibit the effects of tetrahydrocannabinol in the human body
US20220211640A1 (en) Medicinal compositions of cannabinoids and xanthines
JP6537887B2 (ja) めまい改善剤